Sridhar A, Khan D, Flatt PR, Moffett CR, Irwin N.
GLP-1 receptor agonism and GIP receptor antagonism induce substantial alterations in enteroendocrine and islet cell populations in obese high fat fed mice Peptides
Franco-Martínez L, Pardo-Marín L, Sánchez-Mateos L, Muñoz-Prieto A, García-Martínez JD, Cerón JJ, Martínez-Subiela S, Rubio CP, Tvarijonaviciute A.
Serum Ferritin in Obese Dogs: Changes and Comparison with Other Analytes Vet Sci
- O. O. Ojo; D. K. Srinivasan; B. O. Owolabi; P. R. Flatt; Y. H. A. Abdel-Wahab Beneficial effects of tigerinin-1R on glucose homeostasis and beta cell function in mice with diet-induced obesity-diabetes Biochimie
A. M. Lynch; N. Pathak; V. Pathak; F. P. M. O’Harte; P. R. Flatt; N. Irwin; V. A. Gault
A novel DPP IV-resistant C-terminally extended glucagon analogue exhibits weight-lowering and diabetes-protective effects in high-fat-fed mice mediated through glucagon and GLP-1 receptor activation Diabetologia
H. Y. Kim; H. J. Lee; Y. J. Chang; M. Pichavant; S. A. Shore; K. A. Fitzgerald; Y. Iwakura; E. Israel; K. Bolger; J. Faul; R. H. DeKruyff; D. T. Umetsu
Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity Nat Med
- N. Irwin; I. A. Montgomery; R. C. Moffett; P. R. Flatt Chemical cholecystokinin receptor activation protects against obesity-diabetes in high fat fed mice and has sustainable beneficial effects in genetic ob/ob mice Biochem Pharmacol
- N. Irwin; I. A. Montgomery; F. P. O'Harte; P. Frizelle; P. R. Flatt Comparison of the independent and combined metabolic effects of subchronic modulation of CCK and GIP receptor action in obesity-related diabetes Int J Obes (Lond)
L. Lynch; M. Nowak; B. Varghese; J. Clark; A. Hogan; V. Toxavidis; S. Balk; D. O'Shea; C. O'Farrelly; M. Exley
Adipose Tissue Invariant NKT Cells Protect against Diet-Induced Obesity and Metabolic Disorder through Regulatory Cytokine Production Immunity